Anne-Lise Strandmoe

Anne-Lise Strandmoe

Auto-generated profile, based on publicly available information

Anne-Lise Strandmoe

Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2024 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
ASAnne-Lise Strandmoe
Anne-Lise Strandmoe
JBJeroen Bremer
Jeroen Bremer
GDGilles F H Diercks
Gilles F H Diercks
AGAntoni Gostyński
Antoni Gostyński
EAEmanuele Ammatuna
Emanuele Ammatuna
BHBarbara Horváth
Barbara Horváth
Pemphigus vulgaris (PV) is a rare autoimmune bullous disease characterized by blistering of the skin and mucosa owing to the presence of autoantibodies against the desmosome proteins desmoglein 3 and occasionally in conjunction with desmoglein 1. Fundamental research into the pathogenesis of PV has revolutionized its treatment and outcome with rituximab, a B-cell-depleting therapy. The critical contribution of B cells to the pathogenesis of pemphigus is well accepted. However, the exact pathomechanism, mechanisms of onset, disease course and relapse remain unclear. In this narrative review, we provide an overview of the fundamental research progress that has unfolded over the past few centuries to give rise to current and emerging therapies. Furthermore, we summarize the multifaceted roles of B cells in PV, including their development, maturation and antibody activity. Finally, we explored how these various aspects of B-cell function contribute to disease pathogenesis and pave the way for innovative therapeutic interventions.

Verified
Journal Article
Open access
PDF file
LGLucas Gartzke
Lucas Gartzke
KHKoen Hendriks
Koen Hendriks
FHFemke Hoogstra-Berends
Femke Hoogstra-Berends
CJChristian Paul Joschko
Christian Paul Joschko
ASAnne-Lise Strandmoe
Anne-Lise Strandmoe
RHRobert Henning
Robert Henning
The prolonged cooling of cells results in cell death, in which both apoptosis and ferroptosis have been implicated. Preservation solutions such as the University of Wisconsin Cold Storage Solution (UW) encompass approaches addressing both. The use of UW improves survival and thus extends preservation limits, yet it remains unclear how exactly organ preservation solutions exert their cold protection. Thus, we explored cooling effects on lipid peroxidation and adenosine triphosphate (ATP) levels and the actions of blockers of apoptosis and ferroptosis, and of compounds enhancing mitochondrial function. Cooling and rewarming experiments were performed in a cellular transplantation model using Human Embryonic Kidney (HEK) 293 cells. Cell viability was assessed by neutral red assay. Lipid peroxidation levels were measured by Western blot against 4-Hydroxy-Nonenal (4HNE) and the determination of Malondialdehyde (MDA). ATP was measured by luciferase assay. Cooling beyond 5 h in Dulbecco’s Modified Eagle Medium (DMEM) induced complete cell death in HEK293, whereas cooling in UW preserved ~60% of the cells, with a gradual decline afterwards. Cooling-induced cell death was not precluded by inhibiting apoptosis. In contrast, the blocking of ferroptosis by Ferrostatin-1 or maintaining of mitochondrial function by the 6-chromanol SUL150 completely inhibited cell death both in DMEM- and UW-cooled cells. Cooling for 24 h in UW followed by rewarming for 15 min induced a ~50% increase in MDA, while concomitantly lowering ATP by >90%. Treatment with SUL150 of cooled and rewarmed HEK293 effectively precluded the increase in MDA and preserved normal ATP in both DMEM- and UW-cooled cells. Likewise, treatment with Ferrostatin-1 blocked the MDA increase and preserved the ATP of rewarmed UW HEK293 cells. Cooling-induced HEK293 cell death from hypothermia and/or rewarming was caused by ferroptosis rather than apoptosis. UW slowed down ferroptosis during hypothermia, but lipid peroxidation and ATP depletion rapidly ensued upon rewarming, ultimately resulting in complete cell death. Treatment throughout UW cooling with small-molecule Ferrostatin-1 or the 6-chromanol SUL150 effectively prevented ferroptosis, maintained ATP, and limited lipid peroxidation in UW-cooled cells. Counteracting ferroptosis during cooling in UW-based preservation solutions may provide a simple method to improve graft survival following cold static cooling.

3 August 2026 in Journal of Translational Autoimmunity
Verified
Journal Article
Open access
ASAnne-Lise Strandmoe
Anne-Lise Strandmoe
CBCarlo Bonasia
Carlo Bonasia
NINanthicha Inrueangsri
Nanthicha Inrueangsri
WAWayel H. Abdulahad
Wayel H. Abdulahad
ISInge M. Strating
Inge M. Strating
PHPeter Heeringa
Peter Heeringa

29 December 2025 in American Journal of Clinical Dermatology
Verified
Journal Article
Closed access
PDF file
BHBarbara Horváth
Barbara Horváth
MHMarjolein A. J. Hiel
Marjolein A. J. Hiel
ASAnne-Lise Strandmoe
Anne-Lise Strandmoe
JMJoost M. Meijer
Joost M. Meijer